Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone

Journal of Orthopaedic Surgery and Research

Volumn 5, Issue 1, 2010, Pages

  Matsumoto, Yoshihiro ^a   Okada, Yuko ^a   Fukushi, Jun ichi ^a   Kamura, Satoshi ^a   Fujiwara, Toshifumi ^a   Iida, Keiichiro ^a   Koga, Mihoko ^a   Matsuda, Shuichi ^a   Harimaya, Katsumi ^a   Sakamoto, Akio ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049507258     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/1749-799X-5-85     Document Type: Article

References (25)

1. Dahlin DC, Cupps RE, Johnson EW. Giant-cell tumor: a study of 195 cases. Cancer 1970, 25:1061-1070. 10.1002/1097-0142(197005)25:5<1061::AID-CNCR2820250509>3.0.CO;2-E, 4910256.
2. Brecher ME, Franklin WA, Simon MA. Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone. Am J Pathol 1986, 125:252-257. 1888249, 3789086.
3. Miyamoto N, Higuchi Y, Tajima M, Ito M, Tsurudome M, Nishio M, Kawano M, Sudo A, Uchida A, Ito Y. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. J Orthop Res 2000, 18:647-654. 10.1002/jor.1100180418, 11052502.
4. Goldring SR, Roelke MS, Petrison KK, Bhan AK. Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest 1987, 79:483-91. 10.1172/JCI112838, 424109, 3027126.
5. Zheng MH, Fan Y, Wysocki SJ, Lau AT, Robertson T, Beilharz M, Wood DJ, Papadimitriou JM. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol 1994, 145:1095-1104. 1887430, 7977641.
6. Zheng MH, Fan Y, Smith A, Wysocki S, Papadimitriou JM, Wood DJ. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration. J Cell Biochem 1998, 70:121-129. 10.1002/(SICI)1097-4644(19980701)70:1<121::AID-JCB12>3.0.CO;2-S, 9632113.
7. Huang L, Xu J, Wood DJ, Zheng MH. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol 2000, 156:761-767. 1876848, 10702390.
8. Roux S, Quinn J, Pichaud F, Orcel P, Chastre E, Jullienne A, De Vernejoul MC. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone. J Cell Physiol 1996, 168:489-498. 10.1002/(SICI)1097-4652(199609)168:3<489::AID-JCP1>3.0.CO;2-L, 8816903.
9. Matsumoto Y, Tanaka K, Hirata G, Hanada M, Matsuda S, Shuto T, Iwamoto Y. Possible involvement of the vascular endothelial growth factor-flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol 2002, 168:5824-5831.
10. Zheng MH, Xu J, Robbins P, Pavlos N, Wysocki S, Kumta SM, Wood DJ, Papadimitriou JM. Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol 2000, 31:804-812. 10.1053/hupa.2000.8441, 10923916.
11. Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 2000, 15:1477-1488. 10.1359/jbmr.2000.15.8.1477, 10934646.
12. Horner A, Bord S, Kelsall AW, Coleman N, Compston JE. Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. Bone 2001, 28:65-71. 10.1016/S8756-3282(00)00422-1, 11165944.
13. Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y. Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 1987, 48:989-996. 10.1016/0092-8674(87)90707-0, 2951015.
14. Harimaya K, Tanaka K, Matsumoto Y, Sato H, Matsuda S, Iwamoto Y. Antioxidants inhibit TNFα-induced motility and invasion of human osteosarcoma cells: possible involvement of NFκB activation. Clin Exp Metastasis 2000, 18:121-129. 10.1023/A:1006791723233, 11235987.
15. Matsumoto Y, Tanaka K, Harimaya K, Nakatani F, Matsuda S, Iwamoto Y. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosatcoma cells. Jpn J Cancer Res 2001, 92:429-438.
16. O'Connell JX, Wehrli BM, Nielsen GP, Rosenberg AE. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors. Am J Surg Pathol 2000, 24:386-395. 10.1097/00000478-200003000-00007, 10716152.
17. Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Curwen JO, Hennequin LF, Thomas AP, Stokes ES, Curry B, Richmond GH, Wadsworth PF. ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. Cancer Res 2000, 60:970-975.
18. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998, 78:1379-1384. 2063176, 9823983.
19. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000, 151:879-889. 10.1083/jcb.151.4.879, 2169432, 11076971.
20. Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: a clinicopathologic study of prognostic factors. Pathol Int 1998, 48:723-729. 10.1111/j.1440-1827.1998.tb03973.x, 9778111.
21. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 1997, 3:1222-1227. 10.1038/nm1197-1222, 9359696.
22. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996, 87:3336-3343.
23. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Nishikawa S, Kodama H. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 1999, 190:293-298. 10.1084/jem.190.2.293, 2195572, 10432291.
24. Knowles H, Athanasou N. Hypoxia-inducible factor is expressed in giant cell tumor of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol 2008, 215:56-66. 10.1002/path.2319, 18283716.
25. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone and Joint Surg 1987, 69-A:106-114.